Linda Wightman
About Linda Wightman
Linda Wightman is a Senior Director at Travere Therapeutics with extensive experience in supply chain management and clinical trial materials. She has a background in vocational nursing and has held various leadership roles in the pharmaceutical industry, including positions at Amylin Pharmaceuticals and Bristol-Myers Squibb.
Work at Travere Therapeutics
Linda Wightman serves as the Senior Director at Travere Therapeutics, a position she has held since 2020. In this role, she is responsible for overseeing various aspects of the company's operations, particularly focusing on the integration of business requirements into functional processes. Her work emphasizes the importance of information technology and continuous improvements within the organization.
Previous Experience in Pharmaceuticals
Linda Wightman has extensive experience in the pharmaceutical industry. She worked at Amylin Pharmaceuticals as a Lead Analyst from 2001 to 2012, where she focused on Clinical Trial Materials and Product Development. Following this, she served as Associate Director at Ardea Biosciences from 2014 to 2017, managing Clinical Trial Materials. Additionally, she held the position of Senior Supply Chain Specialist at Bristol-Myers Squibb from 2012 to 2014.
Education and Expertise
Linda Wightman studied Vocational Nursing at Pacific College from 1977 to 1979, achieving a Technical degree. She furthered her education at San Diego State University, where she studied Quality Process Improvement and earned a certification from 2008 to 2010. Her educational background supports her expertise in standardizing processes, as evidenced by her authorship and training on technical SOPs and work instructions.
Supply Chain Management Skills
Linda Wightman possesses extensive skills in supply chain management, particularly in demand planning for both clinical and non-clinical needs. She has a strong background in cold chain distribution, logistics, and warehousing practices, which are essential for maintaining the integrity of clinical supplies. Additionally, she serves as the business owner of the corporate ERP system (E1), indicating her significant responsibility in managing enterprise resource planning.